PARTNERS Trial Enrolls Patients for Bundibugyo Virus Treatment in DRC
The PARTNERS clinical trial launches in the Democratic Republic of the Congo to assess antiviral therapies for Bundibugyo virus disease, aiming to identify effective treatments.
Geneva
WHO Approves First Diagnostic Test for Ebola Bundibugyo Virus
The WHO has added the first molecular diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing to support timely detection and control efforts amid the ongoing…
WHO Recommends Clinical Trials for Bundibugyo Ebola Virus Treatments and Vaccine
WHO advisory groups have prioritized specific candidate therapeutics and a vaccine for clinical evaluation to address Ebola disease caused by Bundibugyo virus amid outbreaks in…
WHO Declares Ebola Bundibugyo Outbreak in DRC and Uganda a Public Health Emergency
The World Health Organization recognizes the Ebola Bundibugyo virus outbreak in the Democratic Republic of the Congo and Uganda as a public health emergency, issuing tailored…